2009
10 December 2009
GlaxoSmithKline Business Briefing on Japan and Emerging Markets
Marc Dunoyer, President Asia Pacific Japan and Abbas Hussain, President, Emerging Markets, along with senior members of his management team presented on GSK's Japanese and Emerging Markets businesses. The meeting was attended by over 100 analysts and institutional investors. Slides from the presentations are available to view below.
Marc Dunoyer, Japan - PDF (2.2Mb)
Abbas Hussain, Emerging Markets - PDF (1.8Mb
Fouad Benghalem, Middle East North Africa - PDF (1.8Mb)
Mark Reilly, China - PDF (1.4Mb)
28 October 2009
GlaxoSmithKline 2009 Q3 Results
CEO Andrew Witty talks about latest progress of GSK’s strategic priorities in this series of videos:
Q3 results summary
Progress with strategy
Pipeline update
28 September 2009
Raymond James Vaccines Conference
Dr Thomas Breuer, Senior Vice President Global Clinical R&D Vaccines & Chief Medical Officer, GSK Biologicals, gave a presentation to a group of around 40 investors on 28 September in Paris. Thomas provided an overview of GSK's vaccines business and late-stage pipeline.
View presentation - PDF (2.78Mb)
15 September 2009
Morgan Stanley Global Healthcare Conference
Andrew Witty, CEO, presented at the Morgan Stanley Global Healthcare Unplugged Conference on September 15, 2009 in New York. Andrew opened with five minutes of brief remarks followed by a 'fireside chat' question and answer session.
5 August 2009
Cowen "Hot Wheels" Tour
Dr Thomas Breuer, Senior Vice President Global Clinical R&D Vaccines & Chief Medical Officer, GSK Biologicals, gave a presentation to a group of investors on 5 August in Philadelphia. Thomas provided an overview of GSK's vaccines business and late-stage pipeline.
View Dr Breuer's presentation - PDF 2.78Mb
22 July 2009
GlaxoSmithKline 2009 Q2 Results
Analyst presentation - PDF (2.78Mb)
B&W - PDF (1Mb)
29 May 2009
GlaxoSmithKline Business Briefing on Consumer Healthcare
John Clarke, President, Worldwide Consumer Healthcare, along with senior members of his management team presented on GSK's Consumer Healthcare business. The meeting was attended by around 75 analysts and institutional investors. Slides from the presentations are available to view below.
John M Clarke, Consumer Healthcare Business Review - PDF (2.7Mb)
Tim Wright, Ken James & Peter Harding, Innovation and Marketing Excellence - PDF (6.3Mb)
Ian McPherson, Geographic Expansion and Emerging Markets - PDF (5.2Mb)
Manfred Scheske, GSK’s Global Leadership in Switch: alli Europe Update - PDF (3.5Mb)
15 May 2009
Exane BNP Paribas Healthcare Conference
Dr Thomas Breuer, Senior Vice President Global Clinical R&D Vaccines & Chief Medical Officer, GSK Biologicals, gave a presentation at the Exane BNP Paribas Annual Investor Healthcare Conference on 15 May 2009 in Paris. GSK were one of 13 healthcare companies (including Sanofi-Aventis, UCB, Bayer, Shire and Novo Nordisk) presenting to around 50 institutional investors and portfolio managers. Thomas provided an overview of GSK's vaccines business and late-stage pipeline.
View presentation - Updated - 5 August 2009 (PDF 1.2Mb)
6 May 2009
Bernstein Pharmaceutical Emerging Markets Conference
Abbas Hussain, President, Emerging Markets, gave a presentation at the Bernstein Pharmaceutical Emerging Markets Conference on 6 May 2009 in New York. The presentation was attended by over 100 institutional investors and portfolio managers. Abbas provided an overview of GSK's emerging markets strategy.
17 March 2009
Cowen Health Care Conference
Andrew Witty, Chief Executive Officer, gave a presentation at the Cowen and Company 29th Annual Health Care Conference on 17 March 2009 in Boston. The presentation was attended by over 100 institutional investors and portfolio managers. Andrew provided an overview of the progress being made in implementing the company's strategy.
5 Feb 2009
GlaxoSmithKline 2008 Q4 Results
View analyst presentation - PDF (2.3Mb)
B&W - PDF (2.2Mb)
View Andrew Witty's Q4 video interview